{"chunk_id": "WHO_GUIDELINES(TRAIN DATA)__chunk_639", "source": "WHO_GUIDELINES(TRAIN DATA)", "text": "od and \nup to 12Â months later among women in the control \ngroup was 0.6%, 1.1% and 1.5%, respectively.\nnn Rates of RhD alloimmunization in subsequent \npregnancies were not reported in the trials.\nnn There is no evidence on optimal dose of antenatal \nanti-D prophylaxis and various regimens are \nused. There are two ongoing studies listed in the \nCochrane review, which may help to clarify issues \naround effects and dosage once completed.\nnn Only 60% of Rh-negative primigravidas will have \nan Rh-pos"}